Validity of Six Month L-Thyroxine Dose for Differentiation of Transient or Permanent Congenital Hypothyroidism
Muhammet AsenaMeliha DemiralEdip UnalMurat ÖcalHüseyin DemirbilekMehmet Nuri ÖzbekPublished in: Journal of clinical research in pediatric endocrinology (2020)
Results suggest that LT4 requirement at six months of therapy may be a good marker for predicting transient TSH elevation in patients with eutopic thyroid gland, thus facilitating the decision to halt LT4 therapy.